FDA, Center for Devices and Radiological Health, Office of Surveillance and Biometrics, Medical Product Safety Network, Small Sample Survey - Final Report, Topic: da Vinci Surgical System (November 2013).
The FDA has issued a final report on the small sample survey of surgeons who use the da Vinci Surgical System. The da Vinci Surgical System is a computer-assisted device designed to facilitate minimally invasive surgery. The survey was conducted to better understand the challenges of the system versus conventional surgical procedures. All surgeons reported that learning to use the system was the biggest challenge. Reported benefits of the system included fewer patient complications and shorter hospital stays. Suggestions for improving the system ranged from changes in the system design and training, to mounting the device on the ceiling to allow more space in smaller rooms.
 FDA, Center for Devices and Radiological Health, Office of Surveillance and Biometrics, Medical Product Safety Network, Small Sample Survey - Final Report, Topic: da Vinci Surgical System (November 2013).
Earlier this week Johnson & Johnson agreed to pay a $2.5 billion settlement to an estimated 8,000 patients who needed to have their defective DePuy ASR hip implants replaced. The typical payment for pain and suffering would be about $250,000 per patient. In addition, J&J has agreed to pay all medical costs related to the replacement of the implants. Typically, metal and plastic artificial hips are expected to last 15 years or more, but an internal J&J document estimated that the DePuy ASR model would fail within 5 years in 40% of patients who received it. The DePuy ASR metal-on-metal hip implants are no longer installed in patients, but J&J will likely have to make an additional settlement as the device fails in more patients.
 In re: ASR Hip Implant Products Liability Litigation, case number 1:10-md-02197 (N.D. Ohio).
 Meir, B. "Johnson & Johnson to offer $2.5 billion hip device settlement," NY Times (Nov. 19, 2013).